Combined Hepatocellular Cholangiocarcinomas; Analysis of a Large Database
Clinical medicine. Pathology · 2008-01 · 1
DOI: 10.4137/cpath.s500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical medicine. Pathology, online erschienen am 19.03.2008. Verfasst von Mitchell S Wachtel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
Combined hepatocellular cholangiocarcinoma (combined tumor) has been described as either a variant of hepatoma or a variant of cholangiocarcinoma. Prior studies evaluated fewer than 50 patients with combined tumors, precluding multivariate analyses. Posited was the notion that analysis of a large database would yield more definite answers.
Methods
This study used SEER (Surveillance, Epidemiology, and End Results Program of the National Cancer Institute) to analyze 282 combined tumors, 2,035 intrahepatic cholangiocarcinomas, and 19,336 hepatomas between the years 1973-2003. Multinomial logit regression calculated point estimates and 95% confidence intervals (c.i.) for relative risk (rr). Cox regression calculated point estimates and 95% confidence intervals (c.i.) for hazard ratios (ĥ).
Results
Men less often had cholangiocarcinomas than they had combined tumors (rr = 0.63, c.i. = 0.49-0.81). Hepatomas less often than combined tumors presented with distant spread (rr = 0.56, c.i. = 0.43-0.72). Men (rr = 1.50, c.i. = 1.17-1.93) and patients with a known Asian or Pacific birthplace (rr = 2.36, c.i. = 1.56-3.56) more often had hepatomas than they had combined tumors. Among patients not known to have an Asian/Pacific birthplace, a diagnosis of cholangiocarcinoma (ĥ = 0.72, c.i. = 0.63-0.82) or hepatoma (ĥ = 0.75, c.i. = 0.66-0.86) provided a better prognosis than did a diagnosis of combined tumor.
Conclusion
Combined tumors differ from hepatomas and cholangiocarcinomas in terms of distribution and survival patterns in the population; they should be considered neither cholangiocarcinomas nor hepatomas.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology.
Zitieren
APA
Wachtel, M. S., Zhang, Y., Xu, T., Chiriva-Internati, M., & Frezza, E. E. (2008). Combined Hepatocellular Cholangiocarcinomas; Analysis of a Large Database. Clinical medicine. Pathology, 1. https://doi.org/10.4137/cpath.s500
Vancouver
Wachtel MS, Zhang Y, Xu T, Chiriva-Internati M, Frezza EE. Combined Hepatocellular Cholangiocarcinomas; Analysis of a Large Database. Clinical medicine. Pathology. 2008;1. doi:10.4137/cpath.s500
BibTeX
@article{Wachtel2008,
author = {Wachtel, Mitchell S and Zhang, Yan and Xu, Tom and Chiriva-Internati, Maurizio and Frezza, Eldo E},
title = {Combined Hepatocellular Cholangiocarcinomas; Analysis of a Large Database},
journal = {Clinical medicine. Pathology},
year = {2008},
volume = {1},
doi = {10.4137/cpath.s500}
}
EUVIMED